Herantis Pharma's financial year is the calendar year. During the year, the company publishes an Annual Financial Statements Release and one Interim Report related to accounting period’s first six months. The Financial Statements and Interim Reports will be released around at 9.00 a.m. (Finnish time) on the given dates.

Upcoming events

Date Event
1 Jul 2019 Herantis newsletter for May-June
29 Jul - 27 Aug 2019 Silent period
29 Jul - 27 Aug 2019 Closed window
21-22 Aug 2019 Herantis attending Neurotrophic Factors meeting in Grand Rapids
28 Aug 2019 Interim report on January-June 2019
2 Sep 2019 Herantis newsletter for July-August
10 Sep 2019 Company presentation to Swedish investors at Aktiespararna's event in Stockholm
11-12 Sep 2019 Meet Herantis at NLSDays in Malmö Sweden
18 Sep 2019 Company presentation to investors at Life Science Investor Meetings in Copenhagen
19 Sep 2019 Company presentation at Sijoittaja 2019
28 Sep 2019 Company presentation at Turun talouspäivät
4 Nov 2019 Herantis newsletter for September-October
11-13 Nov 2019 Meet Herantis at BioEurope in Berlin Germany
During the Silent period, the Company will not comment on its financial position, markets or outlooks. During the Silent period, the management will neither meet with capital market or financial media representatives, nor take a stand on matters concerning the Company's financial position or general outlooks.
During the Closed window period, trading of Herantis Pharma shares or derivatives is forbidden for the Insider group.